Cancer Clinical Trial 2017-019

[LCID Study Number: 2017-019]

The Circulating Cell-free Genome Atlas Study (CCGA)

The purpose of the study is to collect biological samples from donors with a new diagnosis of cancer (blood and tumor tissue) and from donors who do not have a diagnosis of cancer (blood) and to study the relationships between the two.

Disease/Condition: Cancer

Department: Hematology and Oncology

Location(s): Lahey Hospital & Medical Center (Burlington); Lahey Medical Center, Peabody

Primary Contact Email: [email protected]

View NCT ID 02889978 on ClinicalTrials.gov
Protocol #: 2017-019
Principal Investigator(s): Kimberly Rieger-Christ
Study Coordinator(s): Sanjna Das
Trial Phase: Sponsor Initiated Study Observational